Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Consolidated Statements of Operations and Comprehensive Loss
Revenue	$ 20,689	$ 18,957	$ 59,406	$ 51,651
Cost of revenue (excluding amortization of intangible assets)	6,625	6,004	18,535	16,099
Amortization of intangible assets	95	95	285	285
Gross profit	13,969	12,858	40,586	35,267
Operating expenses:
Sales and marketing	15,227	16,472	48,692	50,691
General and administrative	3,948	3,683	11,910	11,133
Research and development	2,348	2,068	7,091	6,784
Total operating expenses	21,523	22,223	67,693	68,608
Other operating income:
Gain on sale of product line				7,580
Loss from operations	(7,554)	(9,365)	(27,107)	(25,761)
Other (expense) income:
Interest expense	(1,201)	(1,344)	(3,608)	(4,007)
Other income	152	337	1,010	1,135
Total other expense, net	(1,049)	(1,007)	(2,598)	(2,872)
Loss before income tax expense	(8,603)	(10,372)	(29,705)	(28,633)
Income tax expense			(85)
Net loss	$ (8,603)	$ (10,372)	$ (29,790)	$ (28,633)
Net loss per common share, basic (in dollars per share)	$ (0.19)	$ (0.42)	$ (0.66)	$ (1.16)
Net loss per common share, diluted (in dollars per share)	$ (0.19)	$ (0.42)	$ (0.66)	$ (1.16)
Weighted average common shares outstanding, basic (in shares)	45,421,795	24,703,578	45,351,947	24,648,933
Weighted average common shares outstanding, diluted (in shares)	45,421,795	24,703,578	45,351,947	24,648,933
Comprehensive loss:
Net loss	$ (8,603)	$ (10,372)	$ (29,790)	$ (28,633)
Foreign currency translation adjustment	(2)	51	1	58
Comprehensive loss	$ (8,605)	$ (10,321)	$ (29,789)	$ (28,575)